(ORSTED) Orsted - Ratings and Ratios
Exchange: CO • Country: Denmark • Currency: DKK • Type: Common Stock • ISIN: DK0060094928
ORSTED: Wind Energy, Solar Energy, Bioenergy, Hydrogen Energy, Energy Storage
Ørsted A/S, a global leader in renewable energy, specializes in the development, construction, and operation of offshore and onshore wind farms, solar farms, energy storage facilities, renewable hydrogen plants, and bioenergy facilities. The company operates through three primary segments: Offshore, Onshore, and Bioenergy & Other. The Offshore segment focuses on developing and operating offshore wind farms across Europe, the United States, and the Asia Pacific, while also advancing renewable hydrogen production in key markets. The Onshore segment manages onshore wind and solar farms in the U.S. and Europe, often integrated with energy storage solutions. The Bioenergy & Other segment generates heat and power through combined heat and power (CHP) plants in Denmark, optimizes its gas portfolio, and oversees B2B operations in Denmark and Sweden. Formerly known as DONG Energy A/S, the company rebranded as Ørsted A/S in November 2017 to reflect its strategic shift toward renewable energy. Headquartered in Fredericia, Denmark, Ørsted A/S was founded in 1972 and has since become a pioneer in the transition to green energy.
Ørsted A/S is listed under the ticker symbol ORSTED on the Copenhagen exchange, classified as a common stock in the Electric Utilities sector. With a market capitalization of 118.38 billion DKK, the company represents a significant player in the renewable energy sector. Its forward P/E ratio of 11.25 suggests potential undervaluation relative to future earnings, though the current P/E is not available. The price-to-book ratio of 1.42 indicates moderate valuation relative to book value, while the price-to-sales ratio of 1.67 reflects its revenue generation capabilities. However, the return on equity (RoE) of -0.32% raises concerns about profitability. Technically, the stock is currently trading at 286.60 DKK, below its 20-day SMA of 295.23 and 50-day SMA of 305.19, signaling bearish momentum. The 200-day SMA of 363.60 further highlights the stocks recent decline. Average 20-day volume stands at 425,110 shares, with an ATR of 12.11, indicating moderate volatility.
3-Month Forecast Based onAdditional Sources for ORSTED Stock
ORSTED Stock Overview
Market Cap in USD | 18,319m |
Sector | Utilities |
Industry | Utilities - Renewable |
GiC Sub-Industry | Electric Utilities |
IPO / Inception |
ORSTED Stock Ratings
Growth Rating | -76.9 |
Fundamental | -13.3 |
Dividend Rating | 19.9 |
Rel. Strength | -43.6 |
Analysts | - |
Fair Price Momentum | 198.29 DKK |
Fair Price DCF | - |
ORSTED Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 75.6% |
ORSTED Growth Ratios
Growth Correlation 3m | -0.2% |
Growth Correlation 12m | -70.6% |
Growth Correlation 5y | -89.7% |
CAGR 5y | -17.51% |
CAGR/Max DD 5y | -0.22 |
Sharpe Ratio 12m | -0.03 |
Alpha | -37.19 |
Beta | 0.079 |
Volatility | 46.90% |
Current Volume | 545.5k |
Average Volume 20d | 494.8k |
As of April 26, 2025, the stock is trading at DKK 258.10 with a total of 545,540 shares traded.
Over the past week, the price has changed by -5.46%, over one month by -17.38%, over three months by -2.38% and over the past year by -32.08%.
Neither. Based on ValueRay Fundamental Analyses, Orsted is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -13.29 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ORSTED as of April 2025 is 198.29. This means that ORSTED is currently overvalued and has a potential downside of -23.17%.
Orsted has no consensus analysts rating.
According to ValueRays Forecast Model, ORSTED Orsted will be worth about 214.2 in April 2026. The stock is currently trading at 258.10. This means that the stock has a potential downside of -17.02%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 361.7 | 40.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 214.2 | -17% |